Compounds > methylprednisolone

methylprednisolone and Bile Duct Diseases

methylprednisolone has been researched along with Bile Duct Diseases in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beckebaum, S; Cicinnati, VR; Dogan, N; Hüsing-Kabar, A; Kabar, I; Schmidt, HH1
Alvarez, E; Bañares, R; Barrio, J; Clemente, G; de Diego, A; Núñez, O; Palomo, J; Pérez Calle, JL; Salcedo, M1
Etani, Y; Mushiake, S; Nakayama, M; Ozono, K; Tajiri, H1
Colina, F; Garcia, I; Gómez, R; Gonzalez, I; Loinaz, C; Lumbreras, C; Luque, I; Moreno, C; Moreno, E; Vega, V1
Chung-Park, MJ; Davis, PH; Garcia, M; Mhanna, MJ; Srivastava, MD1

Other Studies

5 other study(ies) available for methylprednisolone and Bile Duct Diseases

ArticleYear
Acute allograft rejection in liver transplant recipients: Incidence, risk factors, treatment success, and impact on graft failure.
    The Journal of international medical research, 2018, Volume: 46, Issue:9

    Topics: Adult; Aged; Allografts; Antilymphocyte Serum; Bile Duct Diseases; Female; Glucocorticoids; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome

2018
[Cytomegalovirus hepatitis and ductopenia in a heart transplant recipient].
    Gastroenterologia y hepatologia, 2003, Volume: 26, Issue:1

    Topics: Acute Disease; Antiviral Agents; Azathioprine; Bile Duct Diseases; Bile Ducts, Intrahepatic; Cytokines; Cytomegalovirus Infections; Drug Therapy, Combination; gamma-Globulins; Ganciclovir; Graft Rejection; Heart Transplantation; Hepatitis, Viral, Human; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Models, Biological; Mycophenolic Acid; Postoperative Complications; Ursodeoxycholic Acid

2003
A favorable response to steroid therapy in a child with drug-associated acute vanishing bile duct syndrome and skin disorder.
    Journal of paediatrics and child health, 2008, Volume: 44, Issue:4

    Topics: Acetaminophen; Bile Acids and Salts; Bile Duct Diseases; Bilirubin; Cefdinir; Cephalosporins; Child; Erythema Multiforme; Humans; Male; Methylprednisolone; Syndrome

2008
OKT3/antithymocyte globulin immunoprophylaxis in the prevention of recurrence of acute vanishing bile duct syndrome in retransplanted patients.
    Transplantation proceedings, 1994, Volume: 26, Issue:6

    Topics: Acute Disease; Antilymphocyte Serum; Bile Duct Diseases; Follow-Up Studies; Graft Rejection; Humans; Incidence; Liver Function Tests; Liver Transplantation; Methylprednisolone; Muromonab-CD3; Postoperative Complications; Recurrence; Reoperation; Syndrome; Time Factors

1994
Efficacy of early immunosuppressive therapy in a child with carbamazepine-associated vanishing bile duct and Stevens-Johnson syndromes.
    Digestive diseases and sciences, 2002, Volume: 47, Issue:1

    Topics: Bile Duct Diseases; Bile Ducts, Intrahepatic; Carbamazepine; Child, Preschool; Cholestasis; Hepatitis B; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methylprednisolone; Pancreatitis; Stevens-Johnson Syndrome; Tacrolimus

2002